Acer Therapeutics Ownership 2024 | Who Owns Acer Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
13.78%
Retail Ownership
86.22%
Institutional Holders
1.00
Acer Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -70 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -22,231 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -53,035 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -474,094 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -927,041 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3,162 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -11,357 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -347 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -136,955 | -100.00% | - | Dec 31, 2023 |
| THOMPSON INVESTMENT MANAGEMENT, INC. | - | - | - | -10 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -76,772 | -100.00% | - | Dec 31, 2023 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,533 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -918,349 | -100.00% | - | Dec 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -80,720 | -100.00% | - | Dec 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,945 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,047 | -100.00% | - | Dec 31, 2023 |
| JFS WEALTH ADVISORS, LLC | - | - | - | -24 | -100.00% | - | Dec 31, 2023 |
Acer Therapeutics's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -70 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -22,231 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -53,035 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -474,094 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -927,041 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3,162 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -11,357 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -347 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -136,955 | -100.00% | - | Dec 31, 2023 |
| THOMPSON INVESTMENT MANAGEMENT, INC. | - | - | - | -10 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -76,772 | -100.00% | - | Dec 31, 2023 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,533 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -918,349 | -100.00% | - | Dec 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -80,720 | -100.00% | - | Dec 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,945 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,047 | -100.00% | - | Dec 31, 2023 |
| JFS WEALTH ADVISORS, LLC | - | - | - | -24 | -100.00% | - | Dec 31, 2023 |
The largest Acer Therapeutics shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Acer Therapeutics (ACER), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| THOMPSON INVESTMENT MANAGEMENT, INC. | - | - | - | -10 | -100.00% | - | Dec 31, 2023 |
| JFS WEALTH ADVISORS, LLC | - | - | - | -24 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -70 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -94 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -347 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -400 | -100.00% | - | Dec 31, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -922 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,047 | -100.00% | - | Dec 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,945 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3,162 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -11,357 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -22,231 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,533 | -100.00% | - | Dec 31, 2023 |
| UNION SQUARE PARK CAPITAL MANAGEMENT, LLC | - | - | - | -26,633 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -53,035 | -100.00% | - | Dec 31, 2023 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -76,772 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Acer Therapeutics's largest institutional buyer is MORGAN STANLEY. The company purchased -1.00 stocks of ACER, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -991,568 | -100.00% | - | Dec 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -927,041 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -918,349 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -474,094 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -136,955 | -100.00% | - | Dec 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -80,720 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -76,772 | -100.00% | - | Dec 31, 2023 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -53,035 | -100.00% | - | Dec 31, 2023 |
| UNION SQUARE PARK CAPITAL MANAGEMENT, LLC | - | - | - | -26,633 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,533 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -22,231 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -11,357 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3,162 | -100.00% | - | Dec 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,945 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,047 | -100.00% | - | Dec 31, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -922 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -400 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -347 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Acer Therapeutics's biggest institutional seller is YAKIRA CAPITAL MANAGEMENT, INC.. The company sold -0.99M shares of ACER, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -991,568 | -100.00% | - | Dec 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -927,041 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -918,349 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -474,094 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -136,955 | -100.00% | - | Dec 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -80,720 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -76,772 | -100.00% | - | Dec 31, 2023 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -53,035 | -100.00% | - | Dec 31, 2023 |
| UNION SQUARE PARK CAPITAL MANAGEMENT, LLC | - | - | - | -26,633 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,533 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -22,231 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -11,357 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -3,162 | -100.00% | - | Dec 31, 2023 |
| SIMPLEX TRADING, LLC | - | - | - | -1,945 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,047 | -100.00% | - | Dec 31, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -922 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -400 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -347 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -94 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -70 | -100.00% | - | Dec 31, 2023 |
| JFS WEALTH ADVISORS, LLC | - | - | - | -24 | -100.00% | - | Dec 31, 2023 |
| THOMPSON INVESTMENT MANAGEMENT, INC. | - | - | - | -10 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
Acer Therapeutics's largest sold out institutional shareholder by shares sold is YAKIRA CAPITAL MANAGEMENT, INC., sold -0.99M shares, valued at -, as of undefined.
Acer Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FPA NEW INCOME INC | 0.64% | 58,897,000 | - | - | Jun 30, 2023 |
| FPA NEW INCOME INC | 0.55% | 50,532,000 | - | - | Jun 30, 2023 |
| BNY Mellon Investment Funds VII, Inc. | 0.42% | 482,940 | - | - | Apr 30, 2022 |
| SOURCE CAPITAL INC /DE/ | 0.36% | 709,000 | - | - | Mar 31, 2024 |
| BNY Mellon Investment Funds VII, Inc. | 0.28% | 325,000 | - | - | Apr 30, 2022 |
| TOUCHSTONE FUNDS GROUP TRUST | 0.27% | 7,040,000 | - | - | Mar 31, 2024 |
| PIONEER SHORT TERM INCOME FUND | 0.17% | 1,100,000 | - | - | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.11% | 496,180 | - | - | Dec 31, 2023 |
| PIONEER SERIES TRUST X | 0.09% | 5,229,404 | - | - | Mar 28, 2024 |
| TOUCHSTONE FUNDS GROUP TRUST | 0.08% | 2,050,000 | - | - | Mar 31, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.07% | 64,767,737 | - | - | Feb 29, 2024 |
| WEITZ FUNDS | 0.06% | 2,022,000 | - | - | Mar 31, 2024 |
| JNL INVESTORS SERIES TRUST | 0.06% | 208,051 | - | - | Sep 30, 2020 |
| TOUCHSTONE FUNDS GROUP TRUST | 0.05% | 1,184,641 | - | - | Mar 31, 2024 |
| VIRTUS OPPORTUNITIES TRUST | 0.04% | 10,155,000 | - | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.03% | 78,723 | - | - | Jan 31, 2024 |
| Thrivent Core Funds | 0.03% | 1,849,602 | - | - | Jan 31, 2024 |
| T. Rowe Price Short-Term Bond Fund, Inc. | 0.03% | 2,468,043 | - | - | Feb 29, 2024 |
| PIONEER SERIES TRUST X | 0.02% | 1,200,000 | - | - | Mar 28, 2024 |
| DIAMOND HILL FUNDS | 0.02% | 1,000,000 | - | - | Dec 31, 2023 |
| MASSMUTUAL PREMIER FUNDS | 0.02% | 591,000 | - | - | Dec 31, 2023 |
| TOUCHSTONE FUNDS GROUP TRUST | 0.02% | 410,301 | - | - | Mar 31, 2024 |
| PIONEER SERIES TRUST X | 0.01% | 445,746 | - | - | Mar 28, 2024 |
| JOHN HANCOCK BOND TRUST | 0.01% | 550,000 | - | - | Feb 29, 2024 |
| FPA FUNDS TRUST | 0.01% | 1,000,000 | - | - | Feb 29, 2024 |
| FPA FUNDS TRUST | 0.00% | 718,000 | - | - | Feb 29, 2024 |
| BNY Mellon Investment Funds III | 0.00% | 1,550,000 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 840,000 | - | - | Jan 31, 2024 |
| PAYDEN & RYGEL INVESTMENT GROUP | 0.00% | 4,370,000 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 12,789 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,214 | - | - | Mar 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 101,671 | - | - | Mar 31, 2024 |
| PAYDEN & RYGEL INVESTMENT GROUP | 0.00% | 2,345,206 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 474,094 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 4,562,352 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,942 | - | - | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 575,000 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 92,102 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 1,010,000 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 10,185 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 8,874 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 1,455 | - | - | Mar 28, 2024 |
| PIONEER SERIES TRUST XIV | 0.00% | 575,000 | - | - | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 443 | - | - | Mar 31, 2024 |
| PIONEER SERIES TRUST XIV | 0.00% | 545,000 | - | - | Mar 28, 2024 |
| Meeder Funds | 0.00% | 669 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 9,873 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 1,820,000 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 42 | - | - | Apr 30, 2021 |
| NORTHERN FUNDS | 0.00% | 6,900 | - | - | Mar 28, 2024 |
| Brighthouse Funds Trust I | 0.00% | 290,000 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 1,495 | - | - | Feb 29, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 2,363 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 900 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 11,728 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,523 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,379 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,016 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 2,418 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,418 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 5,327 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 6,700 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 7,665 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,932 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 565 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 3,513 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 762 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 13 | - | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 2,660 | - | - | Mar 31, 2024 |
| Morningstar Funds Trust | 0.00% | 603,000 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,275 | - | - | Mar 31, 2024 |
| Morningstar Funds Trust | 0.00% | 423,000 | - | - | Jan 31, 2024 |
Acer Therapeutics's largest mutual fund holder by % of total assets is "FPA NEW INCOME INC", owning 58.90M shares, compromising 0.64% of its total assets.
Acer Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 1 | -96.77% |
| 30 Sep, 23 | 31 | 6.90% |
| 30 Jun, 23 | 29 | 7.41% |
| 31 Mar, 23 | 27 | -20.59% |
| 31 Dec, 22 | 34 | 41.67% |
| 30 Sep, 22 | 24 | 9.09% |
| 30 Jun, 22 | 22 | 46.67% |
| 31 Mar, 22 | 15 | -16.67% |
| 31 Dec, 21 | 18 | -18.18% |
| 30 Sep, 21 | 22 | -18.52% |
| 30 Jun, 21 | 27 | -6.90% |
| 31 Mar, 21 | 29 | 11.54% |
| 31 Dec, 20 | 26 | 30.00% |
| 30 Sep, 20 | 20 | -28.57% |
| 30 Jun, 20 | 28 | -17.65% |
| 31 Mar, 20 | 34 | -12.82% |
| 31 Dec, 19 | 39 | 5.41% |
| 30 Sep, 19 | 37 | 8.82% |
| 30 Jun, 19 | 34 | 3.03% |
| 31 Mar, 19 | 33 | 22.22% |
| 31 Dec, 18 | 27 | -6.90% |
| 30 Sep, 18 | 29 | 93.33% |
| 30 Jun, 18 | 15 | - |
| 31 Mar, 18 | 15 | 25.00% |
| 31 Dec, 17 | 12 | 500.00% |
| 30 Sep, 17 | 2 | - |
As of 31 Dec 23, 1 institutions are holding Acer Therapeutics's shares, representing a decrease of -96.77% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 1,000 | -99.98% |
| 30 Sep, 23 | 4,166,030 | 65.90% |
| 30 Jun, 23 | 2,511,113 | -45.32% |
| 31 Mar, 23 | 4,592,690 | 87.62% |
| 31 Dec, 22 | 2,447,855 | 53.16% |
| 30 Sep, 22 | 1,598,255 | 2.81% |
| 30 Jun, 22 | 1,554,547 | 9.52% |
| 31 Mar, 22 | 1,419,369 | -4.02% |
| 31 Dec, 21 | 1,478,775 | -3.15% |
| 30 Sep, 21 | 1,526,794 | -2.35% |
| 30 Jun, 21 | 1,563,581 | -5.52% |
| 31 Mar, 21 | 1,654,965 | -34.60% |
| 31 Dec, 20 | 2,530,676 | 31.80% |
| 30 Sep, 20 | 1,920,071 | -4.09% |
| 30 Jun, 20 | 2,002,006 | -12.90% |
| 31 Mar, 20 | 2,298,634 | -5.31% |
| 31 Dec, 19 | 2,427,458 | -7.18% |
| 30 Sep, 19 | 2,615,123 | 6.06% |
| 30 Jun, 19 | 2,465,750 | -21.40% |
| 31 Mar, 19 | 3,137,156 | 3.56% |
| 31 Dec, 18 | 3,029,395 | 1.20% |
| 30 Sep, 18 | 2,993,592 | 314.97% |
| 30 Jun, 18 | 721,394 | 17.92% |
| 31 Mar, 18 | 611,769 | 10.31% |
| 31 Dec, 17 | 554,615 | 136169.04% |
| 30 Sep, 17 | 407 | - |
Acer Therapeutics (ACER) has 1.00K shares outstanding as of 31 Dec 23, down -99.98% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 0.00% | 0.00% |
| 30 Sep, 23 | 17.03% | 16.16% |
| 30 Jun, 23 | 10.27% | 2.17% |
| 31 Mar, 23 | 21.75% | 9.02% |
| 31 Dec, 22 | 15.53% | 15.73% |
| 30 Sep, 22 | 9.93% | 12.85% |
| 30 Jun, 22 | 8.79% | 8.94% |
| 31 Mar, 22 | 9.92% | 9.23% |
| 31 Dec, 21 | 10.36% | 9.10% |
| 30 Sep, 21 | 10.67% | 8.94% |
| 30 Jun, 21 | 10.93% | 7.98% |
| 31 Mar, 21 | 11.70% | 2.85% |
| 31 Dec, 20 | 20.27% | 7.29% |
| 30 Sep, 20 | 16.68% | 4.47% |
| 30 Jun, 20 | 19.31% | 3.73% |
| 31 Mar, 20 | 22.77% | 3.94% |
| 31 Dec, 19 | 24.05% | 3.58% |
| 30 Sep, 19 | 25.90% | 4.34% |
| 30 Jun, 19 | 24.44% | 2.53% |
| 31 Mar, 19 | 31.10% | 2.48% |
| 31 Dec, 18 | 35.41% | 3.30% |
| 30 Sep, 18 | 32.77% | 35.39% |
| 30 Jun, 18 | 9.62% | 14.45% |
| 31 Mar, 18 | 8.16% | 11.69% |
| 31 Dec, 17 | 8.36% | 5172877.95% |
| 30 Sep, 17 | 0.01% | - |
As of 31 Dec 23, Acer Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | - | -100.00% |
| 30 Sep, 23 | 17 | 70.00% |
| 30 Jun, 23 | 10 | - |
| 31 Mar, 23 | 10 | -37.50% |
| 31 Dec, 22 | 16 | 77.78% |
| 30 Sep, 22 | 9 | -40.00% |
| 30 Jun, 22 | 15 | 200.00% |
| 31 Mar, 22 | 5 | -44.44% |
| 31 Dec, 21 | 9 | 80.00% |
| 30 Sep, 21 | 5 | -44.44% |
| 30 Jun, 21 | 9 | -25.00% |
| 31 Mar, 21 | 12 | 20.00% |
| 31 Dec, 20 | 10 | 100.00% |
| 30 Sep, 20 | 5 | -58.33% |
| 30 Jun, 20 | 12 | - |
| 31 Mar, 20 | 12 | -36.84% |
| 31 Dec, 19 | 19 | -20.83% |
| 30 Sep, 19 | 24 | -14.29% |
| 30 Jun, 19 | 28 | 27.27% |
| 31 Mar, 19 | 22 | 37.50% |
| 31 Dec, 18 | 16 | -36.00% |
| 30 Sep, 18 | 25 | 316.67% |
| 30 Jun, 18 | 6 | -40.00% |
| 31 Mar, 18 | 10 | -9.09% |
| 31 Dec, 17 | 11 | 450.00% |
| 30 Sep, 17 | 2 | - |
- institutional shareholders have increased their position in ACER stock as of 31 Dec 23 compared to 17 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | - | -100.00% |
| 30 Sep, 23 | 3 | -57.14% |
| 30 Jun, 23 | 7 | - |
| 31 Mar, 23 | 7 | -22.22% |
| 31 Dec, 22 | 9 | - |
| 30 Sep, 22 | 9 | 125.00% |
| 30 Jun, 22 | 4 | -33.33% |
| 31 Mar, 22 | 6 | 200.00% |
| 31 Dec, 21 | 2 | -66.67% |
| 30 Sep, 21 | 6 | -33.33% |
| 30 Jun, 21 | 9 | 28.57% |
| 31 Mar, 21 | 7 | -12.50% |
| 31 Dec, 20 | 8 | -20.00% |
| 30 Sep, 20 | 10 | -28.57% |
| 30 Jun, 20 | 14 | -12.50% |
| 31 Mar, 20 | 16 | 23.08% |
| 31 Dec, 19 | 13 | 44.44% |
| 30 Sep, 19 | 9 | 80.00% |
| 30 Jun, 19 | 5 | 66.67% |
| 31 Mar, 19 | 3 | -57.14% |
| 31 Dec, 18 | 7 | - |
| 30 Sep, 18 | - | -100.00% |
| 30 Jun, 18 | 3 | - |
| 31 Mar, 18 | 3 | - |
| 31 Dec, 17 | - | - |
| 30 Sep, 17 | - | - |
- institutional shareholders have reduced their position in ACER stock as of 31 Dec 23 compared to 3 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 1 | -96.77% | 1,000 | -99.98% | 0.00% | 0.00% | - | -100.00% | - | -100.00% |
| 30 Sep, 23 | 31 | 6.90% | 4,166,030 | 65.90% | 17.03% | 16.16% | 17 | 70.00% | 3 | -57.14% |
| 30 Jun, 23 | 29 | 7.41% | 2,511,113 | -45.32% | 10.27% | 2.17% | 10 | - | 7 | - |
| 31 Mar, 23 | 27 | -20.59% | 4,592,690 | 87.62% | 21.75% | 9.02% | 10 | -37.50% | 7 | -22.22% |
| 31 Dec, 22 | 34 | 41.67% | 2,447,855 | 53.16% | 15.53% | 15.73% | 16 | 77.78% | 9 | - |
| 30 Sep, 22 | 24 | 9.09% | 1,598,255 | 2.81% | 9.93% | 12.85% | 9 | -40.00% | 9 | 125.00% |
| 30 Jun, 22 | 22 | 46.67% | 1,554,547 | 9.52% | 8.79% | 8.94% | 15 | 200.00% | 4 | -33.33% |
| 31 Mar, 22 | 15 | -16.67% | 1,419,369 | -4.02% | 9.92% | 9.23% | 5 | -44.44% | 6 | 200.00% |
| 31 Dec, 21 | 18 | -18.18% | 1,478,775 | -3.15% | 10.36% | 9.10% | 9 | 80.00% | 2 | -66.67% |
| 30 Sep, 21 | 22 | -18.52% | 1,526,794 | -2.35% | 10.67% | 8.94% | 5 | -44.44% | 6 | -33.33% |
| 30 Jun, 21 | 27 | -6.90% | 1,563,581 | -5.52% | 10.93% | 7.98% | 9 | -25.00% | 9 | 28.57% |
| 31 Mar, 21 | 29 | 11.54% | 1,654,965 | -34.60% | 11.70% | 2.85% | 12 | 20.00% | 7 | -12.50% |
| 31 Dec, 20 | 26 | 30.00% | 2,530,676 | 31.80% | 20.27% | 7.29% | 10 | 100.00% | 8 | -20.00% |
| 30 Sep, 20 | 20 | -28.57% | 1,920,071 | -4.09% | 16.68% | 4.47% | 5 | -58.33% | 10 | -28.57% |
| 30 Jun, 20 | 28 | -17.65% | 2,002,006 | -12.90% | 19.31% | 3.73% | 12 | - | 14 | -12.50% |
| 31 Mar, 20 | 34 | -12.82% | 2,298,634 | -5.31% | 22.77% | 3.94% | 12 | -36.84% | 16 | 23.08% |
| 31 Dec, 19 | 39 | 5.41% | 2,427,458 | -7.18% | 24.05% | 3.58% | 19 | -20.83% | 13 | 44.44% |
| 30 Sep, 19 | 37 | 8.82% | 2,615,123 | 6.06% | 25.90% | 4.34% | 24 | -14.29% | 9 | 80.00% |
| 30 Jun, 19 | 34 | 3.03% | 2,465,750 | -21.40% | 24.44% | 2.53% | 28 | 27.27% | 5 | 66.67% |
| 31 Mar, 19 | 33 | 22.22% | 3,137,156 | 3.56% | 31.10% | 2.48% | 22 | 37.50% | 3 | -57.14% |
| 31 Dec, 18 | 27 | -6.90% | 3,029,395 | 1.20% | 35.41% | 3.30% | 16 | -36.00% | 7 | - |
| 30 Sep, 18 | 29 | 93.33% | 2,993,592 | 314.97% | 32.77% | 35.39% | 25 | 316.67% | - | -100.00% |
| 30 Jun, 18 | 15 | - | 721,394 | 17.92% | 9.62% | 14.45% | 6 | -40.00% | 3 | - |
| 31 Mar, 18 | 15 | 25.00% | 611,769 | 10.31% | 8.16% | 11.69% | 10 | -9.09% | 3 | - |
| 31 Dec, 17 | 12 | 500.00% | 554,615 | 136169.04% | 8.36% | 5172877.95% | 11 | 450.00% | - | - |
| 30 Sep, 17 | 2 | - | 407 | - | 0.01% | - | 2 | - | - | - |
Acer Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Acer Therapeutics's stock was made by ASELAGE STEVE on Nov 20 2023, selling 483,741 shares at $4.34 per share (valued at $2.10M). The last insider buy of ACER was made by Schelling Chris on Dec 01 2022, buying 819,672 shares at $1.22 per share (worth $1000.00K).
Acer Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2023 | 11 | - | - |
| Q4 2022 | 2 | - | - |
| Q2 2022 | 1 | 2 | 50.00% |
| Q1 2022 | 12 | 3 | 400.00% |
| Q4 2021 | 2 | - | - |
| Q1 2021 | 10 | 2 | 500.00% |
| Q3 2020 | 4 | - | - |
| Q1 2020 | 4 | 1 | 400.00% |
| Q3 2019 | 6 | 5 | 120.00% |
| Q1 2019 | 9 | - | - |
| Q4 2018 | 1 | - | - |
| Q3 2018 | 1 | - | - |
| Q2 2018 | 1 | - | - |
| Q4 2017 | 11 | - | - |
| Q3 2017 | 10 | - | - |
| Q4 2016 | - | 3 | - |
| Q3 2016 | 4 | - | - |
| Q2 2016 | 11 | - | - |
| Q4 2015 | 3 | 7 | 42.86% |
| Q3 2015 | 3 | - | - |
11 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Acer Therapeutics's insiders, as of Q1 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2023 | - | - | - |
| Q4 2022 | 2 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 2 | - | - |
| Q1 2021 | - | - | - |
| Q3 2020 | 4 | - | - |
| Q1 2020 | - | - | - |
| Q3 2019 | 1 | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 1 | - | - |
| Q2 2018 | - | - | - |
| Q4 2017 | 4 | - | - |
| Q3 2017 | - | - | - |
| Q4 2016 | - | 3 | - |
| Q3 2016 | - | - | - |
| Q2 2016 | - | - | - |
| Q4 2015 | - | - | - |
| Q3 2015 | - | - | - |
As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acer Therapeutics's stocks.
Acer Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| BDRX | Biodexa Pharmaceuticals Plc |
| HOTH | Hoth Therapeutics, Inc. |
| ONCR | Oncorus, Inc. |
| LEXX | Lexaria Bioscience Corp. |
| SABS | SAB Biotherapeutics, Inc. |
| KTTA | Pasithea Therapeutics Corp. |
| REVB | Revelation Biosciences, Inc. |
| YS | LakeShore Biopharma Co., Ltd |
| VRAX | Virax Biolabs Group Limited |
| NRBO | NeuroBo Pharmaceuticals, Inc. |
| ATXI | Avenue Therapeutics, Inc. |
ACER Ownership FAQ
Who Owns Acer Therapeutics?
Acer Therapeutics is owned by institutional shareholders (0.00%), insiders (13.78%), and public (86.22%). The largest institutional shareholder of Acer Therapeutics is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is FPA NEW INCOME INC (0.64% of total shares).
Who are the major institutional shareholders of Acer Therapeutics?
Acer Therapeutics's major institutional shareholders are JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, and VANGUARD GROUP INC. The top five shareholders own together 0% of the company's share outstanding.
How many Acer Therapeutics shareholders are there?
As of Dec 2023, there are 1 institutional shareholders of Acer Therapeutics.
What percentage of Acer Therapeutics is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Acer Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of Acer Therapeutics is owned by WELLS FARGO & COMPANY/MN?
As of Dec 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Acer Therapeutics (ACER), compromising 0% of the company, valued at $0.
What percentage of Acer Therapeutics is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Acer Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).